Patterns of Failure and Survival Trends in 3,808 Patients with Stage II Nasopharyngeal Carcinoma Diagnosed from 1990 to 2012: A Large-Scale Retrospective Cohort Study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose The purpose of this study was to investigate the survival trends and patterns of failure in patients with stage II nasopharyngeal carcinoma (NPC) treated with radiotherapy (RT) and chemotherapy over the last 20 years. Materials and Methods Thirty-eight hundred and eight patients diagnosed with stage II NPC between January 1990 and December 2012 were involved in this retrospective cohort study. All patients were treated with RT. According to the main imaging techniques and RT technology, we categorized these patients into four calendar periods: 1990-1996, 1997-2002, 2003-2007, and 2008-2012. Overall survival (OS), progression-free survival (PFS), locoregional relapse-free survival (LRFS), and distant metastasis–free survival (DMFS) were served as the clinical outcome. Results After a median follow-up period of 84.7 months, we observed increasing trends in survival and disease control. The 3- and 5-year OS rates increased from 87.1% and 78.7% in the first calendar period to 97.4% and 94.5% in the last calendar period, respectively (p < 0.001). Additionally, significant increasing trends could be seen in the PFS and LRFS during the four calendar periods. In the subgroup analysis, the LRFS in patients older than 50 years at diagnosis showed greater improvement than younger patients. However, the rate of distant metastasis was stable and relatively low, as the 5-year DMFS ranged from 90.5% to 94.7% among the four calendar periods. Conclusion The survival rates in patients with stage II NPC showed increasing trends from 1990 to 2012. The advance of RT provided excellent locoregional control and enhanced OS.
Abstract
Purpose The purpose of this study was to investigate the survival trends and patterns of failure in patients with stage II nasopharyngeal carcinoma (NPC) treated with radiotherapy (RT) and chemotherapy over the last 20 years. Materials and Methods Thirty-eight hundred and eight patients diagnosed with stage II NPC between January 1990 and December 2012 were involved in this retrospective cohort study. All patients were treated with RT. According to the main imaging techniques and RT technology, we categorized these patients into four calendar periods: 1990-1996, 1997-2002, 2003-2007, and 2008-2012. Overall survival (OS), progression-free survival (PFS), locoregional relapse-free survival (LRFS), and distant metastasis–free survival (DMFS) were served as the clinical outcome. Results After a median follow-up period of 84.7 months, we observed increasing trends in survival and disease control. The 3- and 5-year OS rates increased from 87.1% and 78.7% in the first calendar period to 97.4% and 94.5% in the last calendar period, respectively (p < 0.001). Additionally, significant increasing trends could be seen in the PFS and LRFS during the four calendar periods. In the subgroup analysis, the LRFS in patients older than 50 years at diagnosis showed greater improvement than younger patients. However, the rate of distant metastasis was stable and relatively low, as the 5-year DMFS ranged from 90.5% to 94.7% among the four calendar periods. Conclusion The survival rates in patients with stage II NPC showed increasing trends from 1990 to 2012. The advance of RT provided excellent locoregional control and enhanced OS.
참고문헌 (29)
- Yu MC, "Epidemiology of nasopharyngeal carcinoma", Semin Cancer Biol, 12, pp.421~429 (2002)
- Wee JT, "Is nasopharyngeal cancer really a "Cantonese cancer"?", Chin J Cancer, 29, pp.517~526 (2010)
- Foo KF, "Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type", Ann Oncol, 13, pp.150~156 (2002)
- Lee AW, "Evolution of treatment for nasopharyngeal cancer : success and setback in the intensity-modulated radiotherapy era", Radiother Oncol, 110, pp.377~384 (2014)
- Yi JL, "Nasopharyngeal carcinoma treated by radical radiotherapy alone : ten-year experience of a single institution", Int J Radiat Oncol Biol Phys, 65, pp.161~168 (2006)
- Geara FB, "Carcinoma of the nasopharynx treated by radiotherapy alone : determinants of distant metastasis and survival", Radiother Oncol, 43, pp.53~61 (1997)
- Lee AW, "Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985 : overall survival and patterns of failure", Int J Radiat Oncol Biol Phys, 23, pp.261~270 (1992)
- Sun X, "Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma : an analysis of survival and treatment toxicities", Radiother Oncol, 110, pp.398~403 (2014)
- Lai V, "Nasopharyngeal carcinoma : comparison of diffusion and perfusion characteristics between different tumour stages using intravoxel incoherent motion MR imaging", Eur Radiol, 24, pp.176~183 (2014)
- Lee AW, "Treatment results for nasopharyngeal carcinoma in the modern era : the Hong Kong experience", Int J Radiat Oncol Biol Phys, 61, pp.1107~1116 (2005)
- Yang Z, "Pretreatment(18)F-FDG uptake heterogeneity can predict survival in patients with locally advanced nasopharyngeal carcinoma : a retrospective study", Radiat Oncol, 10, pp.4~ (2015)
- Vellayappan BA, "Accuracy of(18)F-flurodeoxyglucose-positron emission tomography", computed tomography in the staging of newly diagnosed nasopharyngeal carcinoma : a systematic review and meta-analysis, 2014, pp.48, 331~338
- Chen YP, "A Bayesian network meta-analysis comparing concurrent chemoradiotherapy followed by adjuvant chemotherapy, concurrent chemoradiotherapy alone and radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma", Ann Oncol, 26, pp.205~211 (2015)
- Chua DT, "Treatment outcome after radiotherapy alone for patients with stage I-II nasopharyngeal carcinoma", Cancer, 98, pp.74~80 (2003)
- Ma J, "Is the 1997 AJCC staging system for nasopharyngeal carcinoma prognostically useful for Chinese patient populations?", Int J Radiat Oncol Biol Phys, 50, pp.1181~1189 (2001)
- Xiao WW, "Treatment outcomes after radiotherapy alone for patients with early-stage nasopharyngeal carcinoma", Int J Radiat Oncol Biol Phys, 74, pp.1070~1076 (2009)
- Kwong DL, "Intensity-modulated radiotherapy for earlystage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function", Cancer, 101, pp.1584~1593 (2004)
- Edge SB, "The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM", Ann Surg Oncol, 17, pp.1471~1474 (2010)
- Sun Y, "Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensitymodulated radiotherapy", Radiother Oncol, 110, pp.390~397 (2014)
- Zhao C, "Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma", Ai Zheng, 23(11 Suppl), pp.1532~1537 (2004)
- Ngeow J, "Docetaxel is effective in heavily pretreated patients with disseminated nasopharyngeal carcinoma", Ann Oncol, 22, pp.718~722 (2011)
- Hua YJ, "Longterm treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy", Eur J Cancer, 48, pp.3422~3428 (2012)
- Peng G, "A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma", Radiother Oncol, 104, pp.286~293 (2012)
- Zhang MX, "Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: a 10-year experience with a large cohort and long follow-up", Eur J Cancer, 51, pp.2587~2595 (2015)
- Wu F, "Concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma : treatment outcomes of a prospective, multicentric clinical study", Radiother Oncol, 112, pp.106~111 (2014)
- Chen QY, "Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma : phase III randomized trial", J Natl Cancer Inst, 103, pp.1761~1770 (2011)
- 강민규, "Role of Chemotherapy in Stage II Nasopharyngeal Carcinoma Treated with Curative Radiotherapy", Cancer Research and Treatment, 47(4), pp.871~878 (2015), 대한암학회[DOI]
- Tang LQ, "Establishment and validation of prognostic nomograms for endemic nasopharyngeal carcinoma", J Natl Cancer Inst, 108, pp.djv291~ (2016)
- Chua ML, "Nasopharyngeal carcinoma", Lancet, 387, pp.1012~1024 (2016)